Scientists track fluid shifts in sepsis patients to personalize resuscitation

NCT ID NCT06499701

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how a standard dose of IV fluid (Ringer's Lactate) moves between blood and tissues in people with early sepsis. Researchers will measure changes in blood volume and urine output to understand individual differences. The goal is to make fluid treatment more personalized for sepsis patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • "Prof CC Iliescu" Emergency Institue for Cardiovascular Diseases

    RECRUITING

    Bucharest, 022328, Romania

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Fundeni Clinical Institute

    RECRUITING

    Bucharest, Bucharest, 022328, Romania

    Contact Email: •••••@•••••

    Contact